Home › Multiple Myeloma › Colorado

Pag-aaral pangklinika para sa Multiple Myeloma sa Colorado

36 pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa mga site sa Colorado.

Mga Lungsod sa Colorado

Opisyal na teksto ng pag-aaral (English)

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

UCHealth Poudre Valley Hospital, Fort Collins
UCHealth Harmony, Fort Collins
UCHealth Greeley Hospital, Greeley
at 3 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06152575

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Rocky Mountain Cancer Centers - Aurora /ID# 268574, Aurora

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT05650632

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07589634

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT05652335

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07258511

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Local Institution - 0381, Aurora

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT05519085

A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).

Research Site, Denver

Nagre-recruitPhase 3

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07735637

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma

Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center, Denver

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT04910568

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Colorado Blood Cancer Institute /ID# 280275, Denver

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07409246

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

Colorado Blood Cancer Institute /ID# 273129, Denver

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06892522

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Colorado Blood Cancer Institute /ID# 279080, Denver

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07095452

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

Research Site, Denver

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07681596

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

CBCI, Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07648264

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

Research Site, Aurora
Research Site, Denver

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT05850234

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT06297226

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Research Site, Denver

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07391657

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07518186

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06768489

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

Research Site, Denver

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07073547

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06500884

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

Colorado Blood Cancer Institute, Denver
Rocky Mountain Cancer Center, Denver

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07637578

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Penrose-Saint Francis Healthcare, Colorado Springs
Rocky Mountain Cancer Centers-Penrose, Colorado Springs
Saint Francis Cancer Center, Colorado Springs
at 3 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04566328

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Colorado Blood Cancer Institute/SCRI, Denver

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06292780

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Research Site, Aurora
Research Site, Denver

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT07764978

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT05469893

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

UCHealth Poudre Valley Hospital, Fort Collins
UCHealth Harmony, Fort Collins
UCHealth Greeley Hospital, Greeley
at 3 pa

Nagre-recruitPhase 4

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06057402

Integrated Cancer Repository for Cancer Research

Advent Health, Greenwood Village

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Rocky Mountain Regional VA Medical Center, Aurora
Penrose-Saint Francis Healthcare, Colorado Springs
Rocky Mountain Cancer Centers-Penrose, Colorado Springs
at 6 pa

Nagre-recruitPhase 3

Lahat ng edad · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT05561387

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 2

Edad 19 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06974786

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

Colorado Blood Cancer Institute /ID# 273751, Denver

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update May 12, 2026 · NCT06896916

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Colorado Blood Cancer Institute, Denver
Rocky Mountain Cancer Center, Denver

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT05972135

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

GSK Investigational Site, Aurora

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT06679101

Survivors Uniting for Remote Guided Exercise

Human Performance Clinical Research Lab, Fort Collins

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 31, 2026 · NCT07290309

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04988555

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

Colorado Blood Cancer Institute, Denver

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT06153251

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

CU Anschutz Medical Campus, Anshutz Cancer Pavillion, Aurora

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2025 · NCT05722418

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.